Follow
Raphael Gottardo
Raphael Gottardo
Lausanne University Hospital and University of Lausanne
Verified email at chuv.ch - Homepage
Title
Cited by
Cited by
Year
Integrated analysis of multimodal single-cell data
Y Hao, S Hao, E Andersen-Nissen, WM Mauck, S Zheng, A Butler, MJ Lee, ...
Cell 184 (13), 3573-3587. e29, 2021
64102021
Orchestrating high-throughput genomic analysis with Bioconductor
W Huber, VJ Carey, R Gentleman, S Anders, M Carlson, BS Carvalho, ...
Nature methods 12 (2), 115-121, 2015
33722015
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data
G Finak, A McDavid, M Yajima, J Deng, V Gersuk, AK Shalek, CK Slichter, ...
Genome biology 16, 1-13, 2015
22752015
Multiple early factors anticipate post-acute COVID-19 sequelae
Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ...
Cell 185 (5), 881-895. e20, 2022
7552022
Critical assessment of automated flow cytometry data analysis techniques
N Aghaeepour, G Finak, FlowCAP Consortium, Dream Consortium, ...
Nature methods 10 (3), 228-238, 2013
6422013
Orchestrating single-cell analysis with Bioconductor
RA Amezquita, ATL Lun, E Becht, VJ Carey, LN Carpp, L Geistlinger, ...
Nature methods 17 (2), 137-145, 2020
5852020
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions
L Vojtech, S Woo, S Hughes, C Levy, L Ballweber, RP Sauteraud, J Strobl, ...
Nucleic acids research 42 (11), 7290-7304, 2014
5652014
Model-based analysis of tiling-arrays for ChIP-chip
WE Johnson, W Li, CA Meyer, R Gottardo, JS Carroll, M Brown, XS Liu
Proceedings of the National Academy of Sciences 103 (33), 12457-12462, 2006
5002006
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
M Alberer, U Gnad-Vogt, HS Hong, KT Mehr, L Backert, G Finak, ...
The Lancet 390 (10101), 1511-1520, 2017
4832017
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
Y Su, D Chen, D Yuan, C Lausted, J Choi, CL Dai, V Voillet, VR Duvvuri, ...
Cell 183 (6), 1479-1495. e20, 2020
4822020
Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments
A McDavid, G Finak, PK Chattopadyay, M Dominguez, L Lamoreaux, ...
Bioinformatics 29 (4), 461-467, 2013
3952013
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
AI Salter, RG Ivey, JJ Kennedy, V Voillet, A Rajan, EJ Alderman, ...
Science signaling 11 (544), eaat6753, 2018
3872018
Combining mixture components for clustering
JP Baudry, AE Raftery, G Celeux, K Lo, R Gottardo
Journal of computational and graphical statistics 19 (2), 332-353, 2010
3722010
Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies
A deCamp, P Hraber, RT Bailer, MS Seaman, C Ochsenbauer, J Kappes, ...
Journal of virology 88 (5), 2489-2507, 2014
3222014
Automated gating of flow cytometry data via robust model‐based clustering
K Lo, RR Brinkman, R Gottardo
Cytometry Part A: the journal of the International Society for Analytical …, 2008
3182008
Spatial transcriptomics at subspot resolution with BayesSpace
E Zhao, MR Stone, X Ren, J Guenthoer, KS Smythe, T Pulliam, ...
Nature biotechnology 39 (11), 1375-1384, 2021
3152021
Standardizing flow cytometry immunophenotyping analysis from the human immunophenotyping consortium
G Finak, M Langweiler, M Jaimes, M Malek, J Taghiyar, Y Korin, ...
Scientific reports 6 (1), 1-11, 2016
2932016
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, ...
Nature medicine 25 (7), 1064-1072, 2019
2652019
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial
R Gottardo, RT Bailer, BT Korber, S Gnanakaran, J Phillips, X Shen, ...
PloS one 8 (9), e75665, 2013
2572013
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120
N Karasavvas, E Billings, M Rao, C Williams, S Zolla-Pazner, RT Bailer, ...
AIDS research and human retroviruses 28 (11), 1444-1457, 2012
2442012
The system can't perform the operation now. Try again later.
Articles 1–20